Principal Financial Group Inc Axonics, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 37,827 shares of AXNX stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,827

Previous 39,447 4.11%

Holding current value

$2.6 Million

Previous $2.72 Million 6.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$66.47 - $69.65 $107,681 - $112,833	-1,620 Reduced 4.11%	37,827 $2.54 Million
Q1 2024 Apr 29, 2024	SELL	$56.67 - $69.36 $1.49 Million - $1.82 Million	-26,221 Reduced 39.93%	39,447 $2.72 Million
Q4 2023 Feb 07, 2024	BUY	$49.38 - $63.75 $2.66 Million - $3.44 Million	53,965 Added 461.12%	65,668 $4.09 Million
Q3 2023 Nov 02, 2023	SELL	$48.64 - $62.51 $18,191 - $23,378	-374 Reduced 3.1%	11,703 $656,000
Q2 2023 Aug 07, 2023	SELL	$47.99 - $60.21 $8,830 - $11,078	-184 Reduced 1.5%	12,077 $609,000
Q1 2023 May 09, 2023	SELL	$52.6 - $67.34 $4.62 Million - $5.91 Million	-87,772 Reduced 87.74%	12,261 $668,000
Q4 2022 Feb 09, 2023	BUY	$59.56 - $76.6 $4.77 Million - $6.14 Million	80,124 Added 402.45%	100,033 $6.26 Million
Q3 2022 Nov 09, 2022	SELL	$57.96 - $78.12 $7.1 Million - $9.57 Million	-122,495 Reduced 86.02%	19,909 $1.4 Million
Q2 2022 Aug 10, 2022	BUY	$39.5 - $64.42 $1.66 Million - $2.7 Million	41,908 Added 41.7%	142,404 $8.07 Million
Q1 2022 May 09, 2022	BUY	$43.74 - $62.76 $1.29 Million - $1.85 Million	29,415 Added 41.38%	100,496 $6.29 Million
Q4 2021 Feb 09, 2022	SELL	$50.01 - $73.35 $11.2 Million - $16.5 Million	-224,381 Reduced 75.94%	71,081 $3.98 Million
Q3 2021 Nov 09, 2021	SELL	$59.21 - $78.66 $6.31 Million - $8.38 Million	-106,509 Reduced 26.5%	295,462 $19.2 Million
Q2 2021 Aug 10, 2021	BUY	$51.39 - $66.9 $840,123 - $1.09 Million	16,348 Added 4.24%	401,971 $25.5 Million
Q1 2021 May 10, 2021	BUY	$49.14 - $59.89 $18.2 Million - $22.1 Million	369,795 Added 2336.33%	385,623 $23.1 Million
Q4 2020 Feb 08, 2021	BUY	$42.19 - $51.5 $172,936 - $211,098	4,099 Added 34.95%	15,828 $791,000
Q3 2020 Nov 06, 2020	BUY	$35.33 - $51.04 $158,349 - $228,761	4,482 Added 61.85%	11,729 $598,000
Q2 2020 Aug 05, 2020	BUY	$22.91 - $39.83 $166,028 - $288,648	7,247 New	7,247 $254,000

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

42.8M

Call Options Held

73.7K

Put Options Held

230K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.38B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Axonics, Inc. Transaction History